VIVO Cannabis Announces Publication of Medical Cannabis Clinical Research Study in Psychiatric...

Wed, Jun 8

Last week we announced the publication of our first study investigating how medical cannabis impacts anxiety and depression outcomes: https://t.co/hykaC9nuJf

Toronto, Ontario–(Newsfile Corp. – June 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products and patient services, and...

Discover